toxoflavin has been researched along with Disease Models, Animal in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akan, H; Beyer, C; Dees, C; Distler, A; Distler, JH; Distler, O; Gelse, K; Lin, NY; Mallano, T; Palumbo-Zerr, K; Reichert, H; Schett, G; Schramm, A; Varga, J | 1 |
Almonte, V; Chinnasamy, P; Egaña-Gorroño, L; Gross, JN; Guo, L; Jayakumar, S; Parikh, D; Riascos-Bernal, DF; Sibinga, NES | 1 |
Giacomelli, AO; Girgis-Gabardo, A; Hallett, RM; Hassell, JA; Ilieva, D; Kondratyev, MK; Nixon, AM | 1 |
3 other study(ies) available for toxoflavin and Disease Models, Animal
Article | Year |
---|---|
Blockade of canonical Wnt signalling ameliorates experimental dermal fibrosis.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Disease Models, Animal; Fibrosis; Mice; Mice, Inbred DBA; Pyrimidinones; Scleroderma, Systemic; Signal Transduction; Skin; Skin Diseases; Treatment Outcome; Triazines; Wnt Signaling Pathway | 2013 |
Inhibition of Smooth Muscle β-Catenin Hinders Neointima Formation After Vascular Injury.
Topics: Animals; Apoptosis; beta Catenin; Bridged Bicyclo Compounds, Heterocyclic; Carotid Arteries; Carotid Artery Injuries; Cell Movement; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; Genotype; Humans; Male; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Phenotype; Pyrimidinones; Signal Transduction; Time Factors; Triazines; Vascular Remodeling | 2017 |
Small molecule antagonists of the Wnt/β-catenin signaling pathway target breast tumor-initiating cells in a Her2/Neu mouse model of breast cancer.
Topics: Animals; beta Catenin; Breast Neoplasms; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Epithelial Cells; Female; Gene Expression Profiling; Mammary Glands, Animal; Mice; Neoplastic Stem Cells; Pyrimidinones; Receptor, ErbB-2; Triazines; Wnt Proteins; Wnt Signaling Pathway | 2012 |